Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Hepatol. Apr 27, 2013; 5(4): 206-213
Published online Apr 27, 2013. doi: 10.4254/wjh.v5.i4.206
Figure 3
Figure 3 Hepatic apurinic/apyrimidinic endonuclease 1 protein expression in patients with chronic liver disease. A, B: Western blot analysis showed that apurinic/apyrimidinic endonuclease 1 (APE-1) protein levels were reduced in HBV livers compared with normal and HCV livers; HCV livers showed no significant difference in APE-1 protein level compared with normal livers (aP < 0.05 vs HCV, cP < 0.05 vs normal); C: Correlation between hepatocytic APE-1 protein determined by Western blot and immunohistochemistry in patients with chronic hepatitis. G3PDH: Anti-glyceraldehyde-3-phosphate dehydrogenase.